Matricelf Ltd

Tel Aviv Stock Exchange MTLF.TA

Matricelf Ltd Shareholders' Equity for the year ending December 31, 2022: USD 10.17 M

Matricelf Ltd Shareholders' Equity is USD 10.17 M for the year ending December 31, 2022, a 20.49% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Matricelf Ltd Shareholders' Equity for the year ending December 31, 2021 was USD 8.44 M, a 870.44% change year over year.
  • Matricelf Ltd Shareholders' Equity for the year ending December 31, 2020 was USD 869.88 K.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Tel Aviv Stock Exchange: MTLF.TA

Matricelf Ltd

CEO Mr. Alon Sinai
IPO Date June 21, 2021
Location Israel
Headquarters Golda Meir 3
Employees 13
Sector Health Care
Industries
Biotechnology Pharmaceuticals
Description

Matricelf Ltd, a biotechnology company, develops a platform for autologous matrix and cells implants for various medical conditions. Its regenerative medicine platform intends to cure a range of medical conditions, including spinal cord injuries, age-related macular degeneration, Parkinson's disease, and myocardial infarction, as well as for 3D organ printing. Matricelf Ltd was founded in 2019 and is based in Ness Ziona, Israel.

StockViz Staff

January 15, 2025

Any question? Send us an email